Legend Biotech Corporation
LEGN | NASDAQ
$18.79
+$0.26 (+1.40%)
Sep 22, 2026, 11:21 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 1.03B | 627.24M | 285.14M | 117.01M | 68.83M | 75M |
Cost of Revenue | 408.1M | 234.58M | 144.21M | 65.36M | n/a | n/a |
Gross Profit | 620.8M | 392.66M | 140.93M | 51.64M | 68.83M | 75M |
Operating Income | -136.5M | -303.24M | -439.49M | -455.62M | -392.29M | n/a |
Interest Income | 40.1M | 61.2M | 54.49M | 8.18M | 971K | 2.93M |
Pretax Income | -282.6M | -158.13M | -520.12M | -445.72M | -407.2M | -308.29M |
Net Income | -296.8M | -177.03M | -518.25M | -446.35M | -403.58M | -266.37M |
Selling & General & Admin | 341.6M | 284.26M | 200.93M | 174.05M | 149.5M | 72.71M |
Research & Development | 414.7M | 413.54M | 382.22M | 335.65M | 313.35M | 232.16M |
Other Expenses | 1M | -1.91M | -2.73M | -2.43M | -1.74M | -229.87M |
Operating Expenses | 757.3M | 695.9M | 580.41M | 507.26M | 461.11M | 75M |
Interest Expense | 21.4M | 21.62M | 21.79M | 10.8M | 900K | 4.21M |
Selling & Marketing Expenses | 205.8M | 147.48M | 94.16M | 93.42M | 102.54M | 49.57M |
Cost & Expenses | 1.17B | 930.48M | 724.63M | 572.63M | 461.11M | 75M |
Income Tax Expense | 14.2M | 18.89M | -1.86M | 625K | -3.61M | -41.91M |
Shares Outstanding (Basic) | 184.32M | 182.85M | 176.08M | 159.04M | 140.85M | 118.15M |
Shares Outstanding (Diluted) | 184.32M | 182.85M | 176.08M | 159.04M | 140.85M | 118.15M |
EPS (Basic) | -1.60 | -0.97 | -2.94 | -2.81 | -2.74 | -2.57 |
EPS (Diluted) | -1.60 | -0.97 | -2.94 | -2.81 | -2.74 | -2.57 |
EBITDA | -232.3M | -113.16M | -477.87M | -416.54M | -392.38M | -298.16M |
EBIT | -261.2M | -136.52M | -498.32M | -434.93M | -406.3M | -308.09M |
Depreciation & Amortization | 28.9M | 23.36M | 20.45M | 18.39M | 13.92M | 9.93M |
Add to Watchlist
Select watchlists to add or remove LEGN